Filter
166
Filtered Results: 166
Text search:
Pharmacy
and
Poisons
Board
Featured
Recommendations
15
New Publications
43
Language
Document type
No document type
98
Studies & Reports
26
Guidelines
23
Strategic & Response Plan
9
Manuals
5
Fact sheets
3
Training Material
1
Situation Updates
1
Countries / Regions
Kenya
50
Malawi
15
Nigeria
7
Uganda
7
Ethiopia
6
Tanzania
5
Ghana
4
India
4
Sierra Leone
3
Rwanda
3
Western and Central Europe
3
South Africa
3
Namibia
3
Nepal
2
Global
2
Germany
2
East and Southern Africa
2
Bangladesh
2
Zambia
2
Liberia
2
Myanmar / Burma
2
Ukraine
1
Turkey
1
Australia
1
Afghanistan
1
Mozambique
1
Africa
1
Haiti
1
Asia
1
Congo, Democratic Republic of
1
West and Central Africa
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
France
1
United Kingdom
1
Portugal
1
Spain
1
Lebanon
1
Vietnam
1
Brazil
1
Sri Lanka
1
Sudan
1
Bhutan
1
Botswana
1
Indonesia
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Drugs & Medical Equipment
46
Policies
29
Guidelines
27
Studies & Reports
17
Policies & Guidelines HIV & TB
14
COVID-19
4
Demograhic Health Surveys DHS
4
Capacity Building
3
Women & Child Health
2
Community Health
2
Palliative Care
2
Statistics
2
Laboratory Quality Assurance
2
HIV & STI
2
TB
2
Palliative Care
1
Virology
1
Disabilities
1
Humanitarian Crisis
1
Other
1
General Guidelines
1
Toolboxes
Eastern Europe and central Asia
8
Country specific
6
Reports & Studies
6
HIV testing & services
5
Pharmacy Practice
4
Clinical Aspects
3
Prevention Guidelines
3
Quality Assurance
3
Rational use of Medicine
3
Traditional & Herbal Medicines
3
Waste Managment
3
Reports & Studies
3
Africa
2
Preparedness, Response & Risk Communication
2
Preparedness, Response & Risk Communication
2
Country specific documents
2
Advocacy & Communication
2
Pharmacovigilance
2
Co-Morbidities (except TB)
2
Substance Use Disorders & Addiction
2
TB & Prisoners
2
Stewardship
2
Antiretroviral Treatment ART
2
Kenya
2
Assessment & Studies
1
ART Drug Resistance
1
Male Circumcision
1
General Reports
1
Agriculture & Veterinary
1
Clinical Aspects, Treatment & Prevention
1
Chemical Attacks
1
Children & Adolescents
1
Opportunistic Infections
1
Policies & Programmes
1
Substance Use Disorders, Others
1
Public Health
1
Opoids
1
Treatment Guidelines HIV
1
Namibia
1
Global
1
People who injecting Drugs
1
TB & Other Vulnerable Populations
1
Discrimination & Stigma
1
Training
1
Mental Health Studies & Reports
1
Ethiopia
1
International
1
Key Resources
1
Clinical Guidelines
1
Prevention & Preparedness
1
Studies
1
Health Personnel
1
General
1
Clinical Aspects
1
Public Health
1
PPE Personel Protective Equipment
1
Training, others
1
Country Specific
1
Workplace
1
COVID-19
1
Vaccine Candidates & Research
1
Non-pharmaceutical interventions (NPIs)
1
TB/HIV
1
Preparedness, Response & Risk Communication
1
SARS-CoV-2 Variants
1
Others
1
Essential Medicines
1
Essential Medicines & Devices Lists
1
Others
1
Access to treatment and laboratory
1
Women
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Asia and Pacific
1
Malawi
1
Disease Prevention & Control
1
Disaster Preparedness & Prevention
1
Uganda
1
Assessment
1
Testing Guidelines
1
HIV service delivery
1
Reports & Studies Children HIV
1
Lobby and Advocacy
1
HIV in Key Populations
1
Eastern and Southern Africa
1
Training & Capacity Building
1
This new edition and fully updated publication replaces the 2012 UCG and is being circulated free of charge to all public and private sector prescribers, pharmacists, and regulatory authorities in the country
July 2018
This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes the current HIV testing gap; the challenges facing efforts to scale up; and the potential role HIV self-testing (HIVST) could play to achieve the United...
A case study from Bosnia and Herzegovina Eurasian Harm Reduction Network
The case study was prepared by Samir Ibisevic, President of PROI between March and June 2016 and edited by Graham Shaw.
EHRN is grateful to all who contributed to this document, especially: Dr. Serifa Godinjak, Chairperson...
The Health Systems in Transition (HiT) series consists of country-based reviews that provide a detailed description of a health system and of reform and policy initiatives in progress or under development in a specific country.
Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o...
Tuberculosis Infection Control Guidelines
recommended
Second Edition
Specific Objectives
• To increase the knowledge and awareness of personnel on chemical management.
• To educate the personnel on the potential adverse health effects of chemical exposure.
• To educate the personnel on the existing laws pertaining to handling of hazardous
chemicals.
• To...
The intent of these guidelines is to develop a holistic, coordinated, proactive and technology driven strategy for management of biological disasters through a culture of prevention, mitigation and preparedness to generate a prompt and effective response in the event of an emergency. Th...
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
COVID Reference 2021.6 EN
recommended
6th edition 13 January 2021 CR 2021.6.10, uploaded on 27 May 2021
Find eight editions: Deutsch | English | Español | Français | Italiano | Português | Tiếng Việt | Türkçe
https://covidreference.com/download
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in...
Global UNIDO Project: Strengthening the local production of essential medicines in least developed and developing countries
Good Manufacturing Practice (GMP) describes a set of principles and procedures that, when followed, ensure that medicines and related substances are of high quality, safety and efficacy. SAHPRA is a
participating authority of the Pharmaceutical Inspection Cooperation Scheme (jointly known as PIC/S)...
Government of Nepal has an obligation to ensure availability of affordable and high quality basic health care services to its population
